ELAB - Company ID 0001840563
The table below shows Elevai Labs Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $681.99K | $285.95K | - | - | $527.48K | $605.53K |
| Cost of revenue | $451.52K | $207.92K | - | - | $133.58K | $166.28K |
| Gross profit | $230.47K | $78.03K | - | - | $393.90K | $439.25K |
| R&D | $47.06K | $15.00K | $66.67K | $32.43K | $4.10K | $34.82K |
Elevai Labs Inc. reported annual revenue of $590.08K for fiscal year 2025. That is down 65.5% from $1.71M in fiscal 2023. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $1.38M | $726.54K | $319.84K | $209.03K | $167.07K | $148.34K |
| Operating income | - | -$2.20M | - | - | -$625.62K | -$1.41M |
| Income tax | - | - | - | - | - | - |
| Net income | -$4.97M | -$2.59M | -$562.36K | -$1.61M | -$1.50M | -$1.41M |
| EPS (diluted) | - | - | - | - | -$0.07 | -$0.08 |